Organisations / Societies
The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK. Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases. The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.
ABHI is the industry association for the medical technology sector in the UK. ABHI’s purpose is to promote the rapid adoption of medical technologies to ensure optimum patient outcomes throughout the UK and in key global markets. With over 250 company members ABHI is the voice of the medical technology sector, championing industry to the NHS, Government, regulators and stakeholders.
The PHSS exists as a science based Not for Profit society for individuals active in the fields of Pharmaceutical and Healthcare Sciences. The PHSS provides scientific, technical and regulatory knowledge with guidance to professionals in Life Sciences, Healthcare, Bio-Pharmaceuticals, Non Steriles (where bioburden control is required) and Healthcare (particularly Hospital Pharmacies) and related industries.
The PQG is as a voluntary group and is the longest established of the CQI’s special interest groups, which, since 1977, has met the needs of quality professionals within the pharmaceutical industry via open exchange of information and experiences in pharmaceutical quality.
The Pharmaceutical Society of Great Britain was founded on April 15th 1841 by a group of leading London chemists and druggists.
The RSC is the largest organisation in Europe for advancing the chemical sciences. Supported by a worldwide network of members and an international publishing business, our activities span education, conferences, science policy and the promotion of chemistry to the public.
The objectives of S2C2 as laid down in its constitution are: To advance the education of the public in matters relating to the practice and science of contamination control. To assist in the development of contamination control for the benefit of the public, not only for the advancement of the education of the public but also for the furtherance of their health. To assist in the standardisation of effective methods of contamination control.
The British Pharmacopoeia 2014, the only official source of British pharmaceutical standards.
The European Medicines Agency is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.
FDA is responsible for: Protecting the public health by assuring that foods are safe, wholesome, sanitary and properly labeled; human and veterinary drugs, and vaccines and other biological products and medical devices intended for human use are safe and effective. Protecting the public from electronic product radiation. Assuring cosmetics and dietary supplements are safe and properly labeled. Regulating tobacco products. Advancing the public health by helping to speed product innovations. Helping the public get the accurate science-based information they need to use medicines, devices, and foods to improve their health. FDA’s responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa, and other U.S. territories and possessions.
The role of the HPRA is to protect and enhance public and animal health by regulating medicines, medical devices and other health products. It is also our role to monitor the safety of cosmetics.
We are a state agency that puts the health of people and animals at the core of everything we do. We use our scientific and clinical expertise to review and monitor health products available in Ireland or exported abroad. Our aim is to make sure that health products we regulate are as safe as possible and do what they are intended to do.
Formerly known as Irish Medicines Board (IMB), we became the HPRA in July 2014.
The MHRA protects and improves the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.